Animal health company Vets Plus to manufacture and sell FLEX Rx at the beginning of October
MENOMONIE, Wis. (October 12, 2015) - Vets Plus, Inc., the manufacturer of FLEX Rx, will now also be the distributer of the product in OTC channels. The company has expanded its licensing agreement with ProLabs to incorporate the manufacturing and selling of its FLEX Rx joint products.
FLEX Rx chewable tablets offer a specific formulation to support joint health. 46 million households own dogs, and 9.6 million dog owners routinely purchase joint products for their pets. The need for joint supplements is an effect of an aging dog population with obesity, poor diet, or stress to the joints. FLEX Rx is a product intended as a substitute for glucosamine and chondroitin, two common supplements suggested by veterinarians when joint issues arise. In a multi-clinical study, FLEX Rx proved to be more effective than glucosamine and chondroitin for supporting joint function and mobility.
Vets Plus has been currently manufacturing FLEX Rx; with this agreement, Vets Plus will become the exclusive manufacturer and OTC distributor for the product as well. Rick Haxton, National Manager - Companion Animal Business, is leading the partnership on the Vets Plus side. Haxton said, "The addition of FLEX Rx to the Vets Plus product line is an exciting development. Our goal is to improve the overall health of pets by providing them nutritional support. FLEX Rx certainly fulfills this goal, allowing consumers a high-quality product for their pets` joint health."
